Polypeptide Group AG

Polypeptide Group AG

World Rank (Jan-05-2024)
10,686
Market Cap (Jan-05-2024)
0.688 Billion USD
World Rank (Jul-30-2023)
9,898
Market Cap (Jul-30-2023)
0.803 Billion USD
World Rank (Jan-07-2022)
3,795
Market Cap (Jan-07-2022)
4.115 Billion USD
Headquarters Country
Switzerland
Employee Count
973
Employee Count as of Date
As on 2020
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
282 Million USD
Annual Net Income in USD
47 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
595 Million USD
Total Liabilities in USD
173 Million USD
Total Equity in USD
421 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Pharmaceutical
Company Website
POLYPEPTIDE GROUP AG
Company Profile
PolyPeptide Group AG is a Contract Development and Manufacturing Organization (CDMO) focusing on proprietary and generic GMP(Good manufacturing practice) grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products company. The company annual revenue is 223 million EUR, annual operating income is 44.3 million EUR and total assets are 375.9 million EUR as on 2020. The headquarters is in Switzerland.
Founded Year
1952
Stock Exchange
Switzerland

Share